Table 5.
Relationship of cannabis use status to SARS-CoV-2 testing.a
| Adjusted Hazard Ratio (95% Confidence Intervals) |
||
|---|---|---|
| Time-changing cannabis use status | Model 1b | Model 2c |
|
| ||
| Current | 0.83 ( 0.79,0.88)* | 0.80 ( 0.76,0.85)* |
| Recently quit | 1.11 ( 1.08,1.15)* | 1.10 ( 1.06,1.13)* |
| Non-user | 1.00 (reference) | 1.00 (reference) |
a
Outcome was receipt of SARS-CoV-2 PCR tests during pregnancy. Testing was treated as a recurring event outcome. All SARS-CoV-2 PCR tests prior to a patient’s first positive test were included. PCR: polymerase chain reaction.
b
Model 1 is adjusted for age (21 categories: <19, 19–21, one for each year of age up to 39, 40+), race/ethnicity, neighborhood deprivation index, insurance payor, and primary KPNC facility.
c
Model 2 is adjusted for all covariables in Mode1 one plus body mass index, pre-existing diabetes and hypertension, parity, and tobacco smoking status.
*
Significant at p<=0.05